Cite
HARVARD Citation
Ikezoe, T. et al. (2022). Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan. Cancer science. 113 (12), pp. 4258-4266. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ikezoe, T. et al. (2022). Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan. Cancer science. 113 (12), pp. 4258-4266. [Online].